Breaking News

EyePoint Pharmaceuticals to Build GMP Mfg. Facility in Northbridge, MA

To support the global manufacturing of programs, including clinical development and future commercial production for EYP-1901.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

EyePoint Pharmaceuticals, Inc., a company developing and commercializing therapeutics for serious eye disorders, has entered into a lease agreement to design and construct a 40,000-sq.-ft. manufacturing facility in Northbridge, MA to support the global manufacturing of programs, including EYP-1901 and YUTIQ.   The standalone manufacturing facility will be GMP compliant to meet U.S. FDA and European Medicines Agency (EMA) standards and support EYP-1901’s clinical supply and commercial readiness...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters